Taken together, these results support a monitoring strategy centred primarily on SA, complemented by δ‐ALA and AFP for the evaluation of acute neurological risk and HCC development, while suggesting that NTBC concentration should be interpreted cautiously and may offer limited added value beyond ensuring treatment adherence, interpreting unexplained SA elevation, and avoiding excessively low or high exposure. Here, AFP is linked to hepatocellular carcinoma.